OMERS Administration Corp’s Collegium Pharmaceutical COLL Stock Holding History

OMERS Administration Corp’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7,100	Closed	-$248K	–	1111
2025 Q3	$248K	Buy	+7,100	New	+$247K	﹤0.01%	936
2024 Q3	–	Sell	-7,900	Closed	-$254K	–	936
2024 Q2	$254K	Buy	+7,900	New	+$274K	﹤0.01%	840
2019 Q2	–	Sell	-15,700	Closed	-$246K	–	408
2019 Q1	$246K	Buy	+15,700	New	+$251K	﹤0.01%	339
2018 Q2	–	Sell	-22,200	Closed	-$567K	–	403
2018 Q1	$567K	Buy	+22,200	New	+$529K	0.01%	337

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OMERS Administration Corp's COLL Position: Q4 2025 in Review

OMERS Administration Corp sold out of Collegium Pharmaceutical (COLL) in Q4 2025, closing a stake of 7,100 shares — an estimated $248K sold.

OMERS Administration Corp first reported a position in COLL in Q1 2018 and held it in 4 quarters. The position peaked at $567K in Q1 2018. 278 funds tracked by Wall St. Rank hold COLL as of Q4 2025.

OMERS Administration Corp reported no remaining Collegium Pharmaceutical position as of Q4 2025 after selling out during the quarter.
OMERS Administration Corp sold 7,100 Collegium Pharmaceutical shares in Q4 2025, an estimated $248K.
OMERS Administration Corp first reported a position in Collegium Pharmaceutical in Q1 2018 and held it in 4 quarters.
OMERS Administration Corp's Collegium Pharmaceutical position peaked at $567K in Q1 2018.
278 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2025.

Based on OMERS Administration Corp's 13F filing for Q4 2025, filed 13 Feb 2026.